ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Insulin Delivery Devices Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-5K1358
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Insulin Delivery Devices Market Insights Forecast to 2028
BUY CHAPTERS

Global Insulin Delivery Devices Market Research Report 2025

Code: QYRE-Auto-5K1358
Report
August 2025
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
BD
Eli Lilly
Animas
Beta Bionics
Cellnovo Ltd
Copernicus
Dance Biopharm
Debiotech
Insulet
Mannkind
Owen Mumford
Roche
SOOIL
Tandem Diabetes Care
Valeritas
West Pharma
Ypsomed
Novo Nordisk
Medtronic Inc

Insulin Delivery Devices Market Size

The global market for Insulin Delivery Devices was valued at US$ 11720 million in the year 2024 and is projected to reach a revised size of US$ 15060 million by 2031, growing at a CAGR of 3.7% during the forecast period.

Insulin Delivery Devices Market

Insulin Delivery Devices Market

Insulin Delivery Devices include syringes, pens, pumps, and others. The cost of syringes and insulin pens is low, which enables users to opt for them as first choice devices. High cost of insulin pumps and insulin jet injectors poses a challenge to the growth of the market. Insulin pumps and jet injectors also require special care and maintenance, which is an additional cost burden to patients.
In 2017, the insulin pens segment accounted for the largest share of the global insulin delivery devices market. The insulin pens segment is further divided into reusable pens and disposable pens.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Insulin Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Delivery Devices.
The Insulin Delivery Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Insulin Delivery Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insulin Delivery Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Insulin Delivery Devices Market Report

Report Metric Details
Report Name Insulin Delivery Devices Market
Accounted market size in year US$ 11720 million
Forecasted market size in 2031 US$ 15060 million
CAGR 3.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Insulin Pens
  • Insulin Pumps
  • Insulin Syringes
  • Others
Segment by Application
  • Patients/Homecare
  • Hospitals & Clinics
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novo Nordisk, Sanofi, BD, Eli Lilly, Medtronic, Animas, Beta Bionics, Cellnovo, Copernicus, Dance Biopharm, Debiotech, Insulet, MannKind, Owen Mumford, Roche, SOOIL, Tandem Diabetes Care, Valeritas, West Pharma, Ypsomed
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Insulin Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Insulin Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Insulin Delivery Devices Market growing?

Ans: The Insulin Delivery Devices Market witnessing a CAGR of 3.7% during the forecast period 2025-2031.

What is the Insulin Delivery Devices Market size in 2031?

Ans: The Insulin Delivery Devices Market size in 2031 will be US$ 15060 million.

Who are the main players in the Insulin Delivery Devices Market report?

Ans: The main players in the Insulin Delivery Devices Market are Novo Nordisk, Sanofi, BD, Eli Lilly, Medtronic, Animas, Beta Bionics, Cellnovo, Copernicus, Dance Biopharm, Debiotech, Insulet, MannKind, Owen Mumford, Roche, SOOIL, Tandem Diabetes Care, Valeritas, West Pharma, Ypsomed

What are the Application segmentation covered in the Insulin Delivery Devices Market report?

Ans: The Applications covered in the Insulin Delivery Devices Market report are Patients/Homecare, Hospitals & Clinics

What are the Type segmentation covered in the Insulin Delivery Devices Market report?

Ans: The Types covered in the Insulin Delivery Devices Market report are Insulin Pens, Insulin Pumps, Insulin Syringes, Others

1 Insulin Delivery Devices Market Overview
1.1 Product Definition
1.2 Insulin Delivery Devices by Type
1.2.1 Global Insulin Delivery Devices Market Value Comparison by Type (2024 VS 2031)
1.2.2 Insulin Pens
1.2.3 Insulin Pumps
1.2.4 Insulin Syringes
1.2.5 Others
1.3 Insulin Delivery Devices by Application
1.3.1 Global Insulin Delivery Devices Market Value by Application (2024 VS 2031)
1.3.2 Patients/Homecare
1.3.3 Hospitals & Clinics
1.4 Global Insulin Delivery Devices Market Size Estimates and Forecasts
1.4.1 Global Insulin Delivery Devices Revenue 2020-2031
1.4.2 Global Insulin Delivery Devices Sales 2020-2031
1.4.3 Global Insulin Delivery Devices Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Insulin Delivery Devices Market Competition by Manufacturers
2.1 Global Insulin Delivery Devices Sales Market Share by Manufacturers (2020-2025)
2.2 Global Insulin Delivery Devices Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Insulin Delivery Devices Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Insulin Delivery Devices, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Insulin Delivery Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Insulin Delivery Devices, Product Type & Application
2.7 Global Key Manufacturers of Insulin Delivery Devices, Date of Enter into This Industry
2.8 Global Insulin Delivery Devices Market Competitive Situation and Trends
2.8.1 Global Insulin Delivery Devices Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Insulin Delivery Devices Players Market Share by Revenue
2.8.3 Global Insulin Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Insulin Delivery Devices Market Scenario by Region
3.1 Global Insulin Delivery Devices Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Insulin Delivery Devices Sales by Region: 2020-2031
3.2.1 Global Insulin Delivery Devices Sales by Region: 2020-2025
3.2.2 Global Insulin Delivery Devices Sales by Region: 2026-2031
3.3 Global Insulin Delivery Devices Revenue by Region: 2020-2031
3.3.1 Global Insulin Delivery Devices Revenue by Region: 2020-2025
3.3.2 Global Insulin Delivery Devices Revenue by Region: 2026-2031
3.4 North America Insulin Delivery Devices Market Facts & Figures by Country
3.4.1 North America Insulin Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Insulin Delivery Devices Sales by Country (2020-2031)
3.4.3 North America Insulin Delivery Devices Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Insulin Delivery Devices Market Facts & Figures by Country
3.5.1 Europe Insulin Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Insulin Delivery Devices Sales by Country (2020-2031)
3.5.3 Europe Insulin Delivery Devices Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Insulin Delivery Devices Market Facts & Figures by Region
3.6.1 Asia Pacific Insulin Delivery Devices Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Insulin Delivery Devices Sales by Region (2020-2031)
3.6.3 Asia Pacific Insulin Delivery Devices Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Insulin Delivery Devices Market Facts & Figures by Country
3.7.1 Latin America Insulin Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Insulin Delivery Devices Sales by Country (2020-2031)
3.7.3 Latin America Insulin Delivery Devices Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Insulin Delivery Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Insulin Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Insulin Delivery Devices Sales by Country (2020-2031)
3.8.3 Middle East and Africa Insulin Delivery Devices Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Insulin Delivery Devices Sales by Type (2020-2031)
4.1.1 Global Insulin Delivery Devices Sales by Type (2020-2025)
4.1.2 Global Insulin Delivery Devices Sales by Type (2026-2031)
4.1.3 Global Insulin Delivery Devices Sales Market Share by Type (2020-2031)
4.2 Global Insulin Delivery Devices Revenue by Type (2020-2031)
4.2.1 Global Insulin Delivery Devices Revenue by Type (2020-2025)
4.2.2 Global Insulin Delivery Devices Revenue by Type (2026-2031)
4.2.3 Global Insulin Delivery Devices Revenue Market Share by Type (2020-2031)
4.3 Global Insulin Delivery Devices Price by Type (2020-2031)
5 Segment by Application
5.1 Global Insulin Delivery Devices Sales by Application (2020-2031)
5.1.1 Global Insulin Delivery Devices Sales by Application (2020-2025)
5.1.2 Global Insulin Delivery Devices Sales by Application (2026-2031)
5.1.3 Global Insulin Delivery Devices Sales Market Share by Application (2020-2031)
5.2 Global Insulin Delivery Devices Revenue by Application (2020-2031)
5.2.1 Global Insulin Delivery Devices Revenue by Application (2020-2025)
5.2.2 Global Insulin Delivery Devices Revenue by Application (2026-2031)
5.2.3 Global Insulin Delivery Devices Revenue Market Share by Application (2020-2031)
5.3 Global Insulin Delivery Devices Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Insulin Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novo Nordisk Insulin Delivery Devices Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Company Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Insulin Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Insulin Delivery Devices Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 BD
6.3.1 BD Company Information
6.3.2 BD Description and Business Overview
6.3.3 BD Insulin Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BD Insulin Delivery Devices Product Portfolio
6.3.5 BD Recent Developments/Updates
6.4 Eli Lilly
6.4.1 Eli Lilly Company Information
6.4.2 Eli Lilly Description and Business Overview
6.4.3 Eli Lilly Insulin Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Eli Lilly Insulin Delivery Devices Product Portfolio
6.4.5 Eli Lilly Recent Developments/Updates
6.5 Medtronic
6.5.1 Medtronic Company Information
6.5.2 Medtronic Description and Business Overview
6.5.3 Medtronic Insulin Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Medtronic Insulin Delivery Devices Product Portfolio
6.5.5 Medtronic Recent Developments/Updates
6.6 Animas
6.6.1 Animas Company Information
6.6.2 Animas Description and Business Overview
6.6.3 Animas Insulin Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Animas Insulin Delivery Devices Product Portfolio
6.6.5 Animas Recent Developments/Updates
6.7 Beta Bionics
6.7.1 Beta Bionics Company Information
6.7.2 Beta Bionics Description and Business Overview
6.7.3 Beta Bionics Insulin Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Beta Bionics Insulin Delivery Devices Product Portfolio
6.7.5 Beta Bionics Recent Developments/Updates
6.8 Cellnovo
6.8.1 Cellnovo Company Information
6.8.2 Cellnovo Description and Business Overview
6.8.3 Cellnovo Insulin Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Cellnovo Insulin Delivery Devices Product Portfolio
6.8.5 Cellnovo Recent Developments/Updates
6.9 Copernicus
6.9.1 Copernicus Company Information
6.9.2 Copernicus Description and Business Overview
6.9.3 Copernicus Insulin Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Copernicus Insulin Delivery Devices Product Portfolio
6.9.5 Copernicus Recent Developments/Updates
6.10 Dance Biopharm
6.10.1 Dance Biopharm Company Information
6.10.2 Dance Biopharm Description and Business Overview
6.10.3 Dance Biopharm Insulin Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Dance Biopharm Insulin Delivery Devices Product Portfolio
6.10.5 Dance Biopharm Recent Developments/Updates
6.11 Debiotech
6.11.1 Debiotech Company Information
6.11.2 Debiotech Description and Business Overview
6.11.3 Debiotech Insulin Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Debiotech Insulin Delivery Devices Product Portfolio
6.11.5 Debiotech Recent Developments/Updates
6.12 Insulet
6.12.1 Insulet Company Information
6.12.2 Insulet Description and Business Overview
6.12.3 Insulet Insulin Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Insulet Insulin Delivery Devices Product Portfolio
6.12.5 Insulet Recent Developments/Updates
6.13 MannKind
6.13.1 MannKind Company Information
6.13.2 MannKind Description and Business Overview
6.13.3 MannKind Insulin Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.13.4 MannKind Insulin Delivery Devices Product Portfolio
6.13.5 MannKind Recent Developments/Updates
6.14 Owen Mumford
6.14.1 Owen Mumford Company Information
6.14.2 Owen Mumford Description and Business Overview
6.14.3 Owen Mumford Insulin Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Owen Mumford Insulin Delivery Devices Product Portfolio
6.14.5 Owen Mumford Recent Developments/Updates
6.15 Roche
6.15.1 Roche Company Information
6.15.2 Roche Description and Business Overview
6.15.3 Roche Insulin Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Roche Insulin Delivery Devices Product Portfolio
6.15.5 Roche Recent Developments/Updates
6.16 SOOIL
6.16.1 SOOIL Company Information
6.16.2 SOOIL Description and Business Overview
6.16.3 SOOIL Insulin Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.16.4 SOOIL Insulin Delivery Devices Product Portfolio
6.16.5 SOOIL Recent Developments/Updates
6.17 Tandem Diabetes Care
6.17.1 Tandem Diabetes Care Company Information
6.17.2 Tandem Diabetes Care Description and Business Overview
6.17.3 Tandem Diabetes Care Insulin Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Tandem Diabetes Care Insulin Delivery Devices Product Portfolio
6.17.5 Tandem Diabetes Care Recent Developments/Updates
6.18 Valeritas
6.18.1 Valeritas Company Information
6.18.2 Valeritas Description and Business Overview
6.18.3 Valeritas Insulin Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Valeritas Insulin Delivery Devices Product Portfolio
6.18.5 Valeritas Recent Developments/Updates
6.19 West Pharma
6.19.1 West Pharma Company Information
6.19.2 West Pharma Description and Business Overview
6.19.3 West Pharma Insulin Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.19.4 West Pharma Insulin Delivery Devices Product Portfolio
6.19.5 West Pharma Recent Developments/Updates
6.20 Ypsomed
6.20.1 Ypsomed Company Information
6.20.2 Ypsomed Description and Business Overview
6.20.3 Ypsomed Insulin Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Ypsomed Insulin Delivery Devices Product Portfolio
6.20.5 Ypsomed Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Insulin Delivery Devices Industry Chain Analysis
7.2 Insulin Delivery Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Insulin Delivery Devices Production Mode & Process Analysis
7.4 Insulin Delivery Devices Sales and Marketing
7.4.1 Insulin Delivery Devices Sales Channels
7.4.2 Insulin Delivery Devices Distributors
7.5 Insulin Delivery Devices Customer Analysis
8 Insulin Delivery Devices Market Dynamics
8.1 Insulin Delivery Devices Industry Trends
8.2 Insulin Delivery Devices Market Drivers
8.3 Insulin Delivery Devices Market Challenges
8.4 Insulin Delivery Devices Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi
BD
Eli Lilly
Animas
Beta Bionics
Cellnovo Ltd
Copernicus
Dance Biopharm
Debiotech
Insulet
Mannkind
Owen Mumford
Roche
SOOIL
Tandem Diabetes Care
Valeritas
West Pharma
Ypsomed
Novo Nordisk
Medtronic Inc
List of Tables
 Table 1. Global Insulin Delivery Devices Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Insulin Delivery Devices Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Insulin Delivery Devices Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Insulin Delivery Devices Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Insulin Delivery Devices Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Insulin Delivery Devices Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Insulin Delivery Devices Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Insulin Delivery Devices Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Insulin Delivery Devices, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Insulin Delivery Devices, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Insulin Delivery Devices, Product Type & Application
 Table 12. Global Key Manufacturers of Insulin Delivery Devices, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Insulin Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Delivery Devices as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Insulin Delivery Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Insulin Delivery Devices Sales by Region (2020-2025) & (K Units)
 Table 18. Global Insulin Delivery Devices Sales Market Share by Region (2020-2025)
 Table 19. Global Insulin Delivery Devices Sales by Region (2026-2031) & (K Units)
 Table 20. Global Insulin Delivery Devices Sales Market Share by Region (2026-2031)
 Table 21. Global Insulin Delivery Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Insulin Delivery Devices Revenue Market Share by Region (2020-2025)
 Table 23. Global Insulin Delivery Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Insulin Delivery Devices Revenue Market Share by Region (2026-2031)
 Table 25. North America Insulin Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Insulin Delivery Devices Sales by Country (2020-2025) & (K Units)
 Table 27. North America Insulin Delivery Devices Sales by Country (2026-2031) & (K Units)
 Table 28. North America Insulin Delivery Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Insulin Delivery Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Insulin Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Insulin Delivery Devices Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Insulin Delivery Devices Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Insulin Delivery Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Insulin Delivery Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Insulin Delivery Devices Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Insulin Delivery Devices Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Insulin Delivery Devices Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Insulin Delivery Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Insulin Delivery Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Insulin Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Insulin Delivery Devices Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Insulin Delivery Devices Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Insulin Delivery Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Insulin Delivery Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Insulin Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Insulin Delivery Devices Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Insulin Delivery Devices Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Insulin Delivery Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Insulin Delivery Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Insulin Delivery Devices Sales (K Units) by Type (2020-2025)
 Table 51. Global Insulin Delivery Devices Sales (K Units) by Type (2026-2031)
 Table 52. Global Insulin Delivery Devices Sales Market Share by Type (2020-2025)
 Table 53. Global Insulin Delivery Devices Sales Market Share by Type (2026-2031)
 Table 54. Global Insulin Delivery Devices Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Insulin Delivery Devices Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Insulin Delivery Devices Revenue Market Share by Type (2020-2025)
 Table 57. Global Insulin Delivery Devices Revenue Market Share by Type (2026-2031)
 Table 58. Global Insulin Delivery Devices Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Insulin Delivery Devices Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Insulin Delivery Devices Sales (K Units) by Application (2020-2025)
 Table 61. Global Insulin Delivery Devices Sales (K Units) by Application (2026-2031)
 Table 62. Global Insulin Delivery Devices Sales Market Share by Application (2020-2025)
 Table 63. Global Insulin Delivery Devices Sales Market Share by Application (2026-2031)
 Table 64. Global Insulin Delivery Devices Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Insulin Delivery Devices Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Insulin Delivery Devices Revenue Market Share by Application (2020-2025)
 Table 67. Global Insulin Delivery Devices Revenue Market Share by Application (2026-2031)
 Table 68. Global Insulin Delivery Devices Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Insulin Delivery Devices Price (USD/Unit) by Application (2026-2031)
 Table 70. Novo Nordisk Company Information
 Table 71. Novo Nordisk Description and Business Overview
 Table 72. Novo Nordisk Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Novo Nordisk Insulin Delivery Devices Product
 Table 74. Novo Nordisk Recent Developments/Updates
 Table 75. Sanofi Company Information
 Table 76. Sanofi Description and Business Overview
 Table 77. Sanofi Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Sanofi Insulin Delivery Devices Product
 Table 79. Sanofi Recent Developments/Updates
 Table 80. BD Company Information
 Table 81. BD Description and Business Overview
 Table 82. BD Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. BD Insulin Delivery Devices Product
 Table 84. BD Recent Developments/Updates
 Table 85. Eli Lilly Company Information
 Table 86. Eli Lilly Description and Business Overview
 Table 87. Eli Lilly Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Eli Lilly Insulin Delivery Devices Product
 Table 89. Eli Lilly Recent Developments/Updates
 Table 90. Medtronic Company Information
 Table 91. Medtronic Description and Business Overview
 Table 92. Medtronic Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Medtronic Insulin Delivery Devices Product
 Table 94. Medtronic Recent Developments/Updates
 Table 95. Animas Company Information
 Table 96. Animas Description and Business Overview
 Table 97. Animas Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Animas Insulin Delivery Devices Product
 Table 99. Animas Recent Developments/Updates
 Table 100. Beta Bionics Company Information
 Table 101. Beta Bionics Description and Business Overview
 Table 102. Beta Bionics Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Beta Bionics Insulin Delivery Devices Product
 Table 104. Beta Bionics Recent Developments/Updates
 Table 105. Cellnovo Company Information
 Table 106. Cellnovo Description and Business Overview
 Table 107. Cellnovo Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Cellnovo Insulin Delivery Devices Product
 Table 109. Cellnovo Recent Developments/Updates
 Table 110. Copernicus Company Information
 Table 111. Copernicus Description and Business Overview
 Table 112. Copernicus Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Copernicus Insulin Delivery Devices Product
 Table 114. Copernicus Recent Developments/Updates
 Table 115. Dance Biopharm Company Information
 Table 116. Dance Biopharm Description and Business Overview
 Table 117. Dance Biopharm Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Dance Biopharm Insulin Delivery Devices Product
 Table 119. Dance Biopharm Recent Developments/Updates
 Table 120. Debiotech Company Information
 Table 121. Debiotech Description and Business Overview
 Table 122. Debiotech Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Debiotech Insulin Delivery Devices Product
 Table 124. Debiotech Recent Developments/Updates
 Table 125. Insulet Company Information
 Table 126. Insulet Description and Business Overview
 Table 127. Insulet Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Insulet Insulin Delivery Devices Product
 Table 129. Insulet Recent Developments/Updates
 Table 130. MannKind Company Information
 Table 131. MannKind Description and Business Overview
 Table 132. MannKind Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 133. MannKind Insulin Delivery Devices Product
 Table 134. MannKind Recent Developments/Updates
 Table 135. Owen Mumford Company Information
 Table 136. Owen Mumford Description and Business Overview
 Table 137. Owen Mumford Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 138. Owen Mumford Insulin Delivery Devices Product
 Table 139. Owen Mumford Recent Developments/Updates
 Table 140. Roche Company Information
 Table 141. Roche Description and Business Overview
 Table 142. Roche Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 143. Roche Insulin Delivery Devices Product
 Table 144. Roche Recent Developments/Updates
 Table 145. SOOIL Company Information
 Table 146. SOOIL Description and Business Overview
 Table 147. SOOIL Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 148. SOOIL Insulin Delivery Devices Product
 Table 149. SOOIL Recent Developments/Updates
 Table 150. Tandem Diabetes Care Company Information
 Table 151. Tandem Diabetes Care Description and Business Overview
 Table 152. Tandem Diabetes Care Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 153. Tandem Diabetes Care Insulin Delivery Devices Product
 Table 154. Tandem Diabetes Care Recent Developments/Updates
 Table 155. Valeritas Company Information
 Table 156. Valeritas Description and Business Overview
 Table 157. Valeritas Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 158. Valeritas Insulin Delivery Devices Product
 Table 159. Valeritas Recent Developments/Updates
 Table 160. West Pharma Company Information
 Table 161. West Pharma Description and Business Overview
 Table 162. West Pharma Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 163. West Pharma Insulin Delivery Devices Product
 Table 164. West Pharma Recent Developments/Updates
 Table 165. Ypsomed Company Information
 Table 166. Ypsomed Description and Business Overview
 Table 167. Ypsomed Insulin Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 168. Ypsomed Insulin Delivery Devices Product
 Table 169. Ypsomed Recent Developments/Updates
 Table 170. Key Raw Materials Lists
 Table 171. Raw Materials Key Suppliers Lists
 Table 172. Insulin Delivery Devices Distributors List
 Table 173. Insulin Delivery Devices Customers List
 Table 174. Insulin Delivery Devices Market Trends
 Table 175. Insulin Delivery Devices Market Drivers
 Table 176. Insulin Delivery Devices Market Challenges
 Table 177. Insulin Delivery Devices Market Restraints
 Table 178. Research Programs/Design for This Report
 Table 179. Key Data Information from Secondary Sources
 Table 180. Key Data Information from Primary Sources
 Table 181. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Insulin Delivery Devices
 Figure 2. Global Insulin Delivery Devices Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Insulin Delivery Devices Market Share by Type: 2024 & 2031
 Figure 4. Insulin Pens Product Picture
 Figure 5. Insulin Pumps Product Picture
 Figure 6. Insulin Syringes Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Insulin Delivery Devices Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Insulin Delivery Devices Market Share by Application: 2024 & 2031
 Figure 10. Patients/Homecare
 Figure 11. Hospitals & Clinics
 Figure 12. Global Insulin Delivery Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Insulin Delivery Devices Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Insulin Delivery Devices Sales (2020-2031) & (K Units)
 Figure 15. Global Insulin Delivery Devices Average Price (USD/Unit) & (2020-2031)
 Figure 16. Insulin Delivery Devices Report Years Considered
 Figure 17. Insulin Delivery Devices Sales Share by Manufacturers in 2024
 Figure 18. Global Insulin Delivery Devices Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Insulin Delivery Devices Players: Market Share by Revenue in Insulin Delivery Devices in 2024
 Figure 20. Insulin Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Insulin Delivery Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Insulin Delivery Devices Sales Market Share by Country (2020-2031)
 Figure 23. North America Insulin Delivery Devices Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Insulin Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Insulin Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Insulin Delivery Devices Sales Market Share by Country (2020-2031)
 Figure 27. Europe Insulin Delivery Devices Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Insulin Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Insulin Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Insulin Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Insulin Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Insulin Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Insulin Delivery Devices Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Insulin Delivery Devices Revenue Market Share by Region (2020-2031)
 Figure 35. China Insulin Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Insulin Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Insulin Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Insulin Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Insulin Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Insulin Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Insulin Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Insulin Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Insulin Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Insulin Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Insulin Delivery Devices Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Insulin Delivery Devices Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Insulin Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Insulin Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Insulin Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Insulin Delivery Devices Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Insulin Delivery Devices Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Insulin Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Insulin Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Insulin Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Insulin Delivery Devices by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Insulin Delivery Devices by Type (2020-2031)
 Figure 57. Global Insulin Delivery Devices Price (USD/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Insulin Delivery Devices by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Insulin Delivery Devices by Application (2020-2031)
 Figure 60. Global Insulin Delivery Devices Price (USD/Unit) by Application (2020-2031)
 Figure 61. Insulin Delivery Devices Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Insulin Drug Delivery Devices Market Insights Forecast to 2030
Global Diabetes Treatment Medical Devices Market Research Report 2024
Insulin Pen and Pump Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diabetes Insulin Delivery Pens Market Insights Forecast to 2030
Global Portable Diabetes Insulin Delivery Pen Market Research Report 2024
Insulin Injection Pen Market
Global Diabetes Delivery Pens Market Research Report 2024
Global Insulin Pen Injectors Market Insights Forecast to 2030
Global Insulin Pen Market Insights Forecast to 2030
Global Insulin Injection Devices Market Research Report 2024
Global Smart Insulin Injection Pens Market Research Report 2025
Global Insulin Pump Market Research Report 2025
Insulin Pen and Pen Needle Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Safety Insulin Pen Needles Market
Global Standard Insulin Pen Needles Market Insights Forecast to 2030
Global Insulin Injection Equipment Market Research Report 2025
Global Diabetes Insulin Pumps Market Research Report 2024
Diabetes Injection Pens Market
Global Insulin Delivery Pens Market Research Report 2024
Global Tube Insulin Pumps Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions